Literature DB >> 25313974

The National Institutes of Health undiagnosed diseases program.

Cynthia J Tifft1, David R Adams.   

Abstract

PURPOSE OF REVIEW: To review the approach to undiagnosed patients and results of the National Institutes of Health (NIH) undiagnosed diseases program (UDP), and discuss its benefits to patients, academic medical centers, and the greater scientific community. RECENT
FINDINGS: The NIH UDP provides comprehensive and collaborative evaluations for patients with objective findings of disease whose diagnoses have long eluded the medical community. Intensive review of patient records, careful phenotyping, and new genomic technologies have resulted in the diagnosis of new and extremely rare conditions, expanded the phenotypes of rare disorders, and determined that symptoms are caused by more than one disorder in a family.
SUMMARY: Many children and adults with complex phenotypes remain undiagnosed despite years of searching. The most common undiagnosed disorders involve a neurologic phenotype. Comprehensive phenotyping and genomic analysis utilizing nuclear families can provide a diagnosis in some cases and provide good 'lead' candidate genes for others. A UDP can be important for patients, academic medical centers, the scientific community, and society.

Entities:  

Mesh:

Year:  2014        PMID: 25313974      PMCID: PMC4302336          DOI: 10.1097/MOP.0000000000000155

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  11 in total

1.  NT5E mutations and arterial calcifications.

Authors:  Cynthia St Hilaire; Shira G Ziegler; Thomas C Markello; Alfredo Brusco; Catherine Groden; Fred Gill; Hannah Carlson-Donohoe; Robert J Lederman; Marcus Y Chen; Dan Yang; Michael P Siegenthaler; Carlo Arduino; Cecilia Mancini; Bernard Freudenthal; Horia C Stanescu; Anselm A Zdebik; R Krishna Chaganti; Robert L Nussbaum; Robert Kleta; William A Gahl; Manfred Boehm
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

2.  The NIH Undiagnosed Diseases Program: lessons learned.

Authors:  William A Gahl; Cynthia J Tifft
Journal:  JAMA       Date:  2011-05-11       Impact factor: 56.272

3.  ERCC6 dysfunction presenting as progressive neurological decline with brain hypomyelination.

Authors:  Laila Shehata; Dimitre R Simeonov; Anja Raams; Lynne Wolfe; Adeline Vanderver; Xueli Li; Yan Huang; Shannon Garner; Cornelius F Boerkoel; Audrey Thurm; Gail E Herman; Cynthia J Tifft; Miao He; Nicolaas G J Jaspers; William A Gahl
Journal:  Am J Med Genet A       Date:  2014-09-22       Impact factor: 2.802

4.  Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity.

Authors:  David R Adams; Hongjie Yuan; Todd Holyoak; Katrina H Arajs; Parvin Hakimi; Thomas C Markello; Lynne A Wolfe; Thierry Vilboux; Barbara K Burton; Karin Fuentes Fajardo; George Grahame; Conisha Holloman; Murat Sincan; Ann C M Smith; Gordon A Wells; Yan Huang; Hugo Vega; James P Snyder; Gretchen A Golas; Cynthia J Tifft; Cornelius F Boerkoel; Richard W Hanson; Stephen F Traynelis; Douglas S Kerr; William A Gahl
Journal:  Mol Genet Metab       Date:  2014-04-13       Impact factor: 4.797

5.  Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum.

Authors:  Thomas C Markello; Laura K Pak; Cynthia St Hilaire; Heidi Dorward; Shira G Ziegler; Marcus Y Chen; Krishna Chaganti; Robert L Nussbaum; Manfred Boehm; William A Gahl
Journal:  Mol Genet Metab       Date:  2011-02-03       Impact factor: 4.797

6.  Glycosylation, hypogammaglobulinemia, and resistance to viral infections.

Authors:  Mohammed A Sadat; Susan Moir; Tae-Wook Chun; Paolo Lusso; Gerardo Kaplan; Lynne Wolfe; Matthew J Memoli; Miao He; Hugo Vega; Leo J Y Kim; Yan Huang; Nadia Hussein; Elma Nievas; Raquel Mitchell; Mary Garofalo; Aaron Louie; Derek C Ireland; Claire Grunes; Raffaello Cimbro; Vyomesh Patel; Genevieve Holzapfel; Daniel Salahuddin; Tyler Bristol; David Adams; Beatriz E Marciano; Madhuri Hegde; Yuxing Li; Katherine R Calvo; Jennifer Stoddard; J Shawn Justement; Jerome Jacques; Debra A Long Priel; Danielle Murray; Peter Sun; Douglas B Kuhns; Cornelius F Boerkoel; John A Chiorini; Giovanni Di Pasquale; Daniela Verthelyi; Sergio D Rosenzweig
Journal:  N Engl J Med       Date:  2014-04-09       Impact factor: 91.245

7.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders.

Authors:  Yaping Yang; Donna M Muzny; Jeffrey G Reid; Matthew N Bainbridge; Alecia Willis; Patricia A Ward; Alicia Braxton; Joke Beuten; Fan Xia; Zhiyv Niu; Matthew Hardison; Richard Person; Mir Reza Bekheirnia; Magalie S Leduc; Amelia Kirby; Peter Pham; Jennifer Scull; Min Wang; Yan Ding; Sharon E Plon; James R Lupski; Arthur L Beaudet; Richard A Gibbs; Christine M Eng
Journal:  N Engl J Med       Date:  2013-10-02       Impact factor: 91.245

8.  The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases.

Authors:  William A Gahl; Thomas C Markello; Camilo Toro; Karin Fuentes Fajardo; Murat Sincan; Fred Gill; Hannah Carlson-Donohoe; Andrea Gropman; Tyler Mark Pierson; Gretchen Golas; Lynne Wolfe; Catherine Groden; Rena Godfrey; Michele Nehrebecky; Colleen Wahl; Dennis M D Landis; Sandra Yang; Anne Madeo; James C Mullikin; Cornelius F Boerkoel; Cynthia J Tifft; David Adams
Journal:  Genet Med       Date:  2011-09-26       Impact factor: 8.822

9.  Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases.

Authors:  Tyler Mark Pierson; David Adams; Florian Bonn; Paola Martinelli; Praveen F Cherukuri; Jamie K Teer; Nancy F Hansen; Pedro Cruz; James C Mullikin For The Nisc Comparative Sequencing Program; Robert W Blakesley; Gretchen Golas; Justin Kwan; Anthony Sandler; Karin Fuentes Fajardo; Thomas Markello; Cynthia Tifft; Craig Blackstone; Elena I Rugarli; Thomas Langer; William A Gahl; Camilo Toro
Journal:  PLoS Genet       Date:  2011-10-13       Impact factor: 5.917

10.  A general framework for estimating the relative pathogenicity of human genetic variants.

Authors:  Martin Kircher; Daniela M Witten; Preti Jain; Brian J O'Roak; Gregory M Cooper; Jay Shendure
Journal:  Nat Genet       Date:  2014-02-02       Impact factor: 38.330

View more
  15 in total

Review 1.  Genomic medicine for undiagnosed diseases.

Authors:  Anastasia L Wise; Teri A Manolio; George A Mensah; Josh F Peterson; Dan M Roden; Cecelia Tamburro; Marc S Williams; Eric D Green
Journal:  Lancet       Date:  2019-08-05       Impact factor: 79.321

2.  The diagnostic odyssey: insights from parents of children living with an undiagnosed condition.

Authors:  Alicia Bauskis; Cecily Strange; Caron Molster; Colleen Fisher
Journal:  Orphanet J Rare Dis       Date:  2022-06-18       Impact factor: 4.303

3.  The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine.

Authors:  William A Gahl; John J Mulvihill; Camilo Toro; Thomas C Markello; Anastasia L Wise; Rachel B Ramoni; David R Adams; Cynthia J Tifft
Journal:  Mol Genet Metab       Date:  2016-01-22       Impact factor: 4.797

4.  High-throughput behavioral assay to investigate seizure sensitivity in zebrafish implicates ZFHX3 in epilepsy.

Authors:  Tyson D Fuller; Trudi A Westfall; Tirthasree Das; Deborah V Dawson; Diane C Slusarski
Journal:  J Neurogenet       Date:  2018-05-02       Impact factor: 1.250

5.  In sickness and in health: context matters when considering potential benefits and risks of genome-wide sequencing.

Authors:  Kimberly A Strong; Thomas May; Shawn A Levy
Journal:  Genet Med       Date:  2015-08       Impact factor: 8.822

6.  Rare and undiagnosed liver diseases: challenges and opportunities.

Authors:  Luca Fabris; Mario Strazzabosco
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

7.  ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13.

Authors:  Yihan Zhang; Haigen Huang; Gexin Zhao; Tadafumi Yokoyama; Hugo Vega; Yan Huang; Raman Sood; Kevin Bishop; Valerie Maduro; John Accardi; Camilo Toro; Cornelius F Boerkoel; Karen Lyons; William A Gahl; Xiaohong Duan; May Christine V Malicdan; Shuo Lin
Journal:  PLoS Genet       Date:  2017-02-03       Impact factor: 5.917

8.  Implementing the Single Institutional Review Board Model: Lessons from the Undiagnosed Diseases Network.

Authors:  Kimberly Splinter; Sara Chandros Hull; Ingrid A Holm; Tara L McDonough; Anastasia L Wise; Rachel B Ramoni
Journal:  Clin Transl Sci       Date:  2017-10-23       Impact factor: 4.689

Review 9.  Model Organisms Facilitate Rare Disease Diagnosis and Therapeutic Research.

Authors:  Michael F Wangler; Shinya Yamamoto; Hsiao-Tuan Chao; Jennifer E Posey; Monte Westerfield; John Postlethwait; Philip Hieter; Kym M Boycott; Philippe M Campeau; Hugo J Bellen
Journal:  Genetics       Date:  2017-09       Impact factor: 4.562

10.  Initiating an undiagnosed diseases program in the Western Australian public health system.

Authors:  Gareth Baynam; Stephanie Broley; Alicia Bauskis; Nicholas Pachter; Fiona McKenzie; Sharron Townshend; Jennie Slee; Cathy Kiraly-Borri; Anand Vasudevan; Anne Hawkins; Lyn Schofield; Petra Helmholz; Richard Palmer; Stefanie Kung; Caroline E Walker; Caron Molster; Barry Lewis; Kym Mina; John Beilby; Gargi Pathak; Cathryn Poulton; Tudor Groza; Andreas Zankl; Tony Roscioli; Marcel E Dinger; John S Mattick; William Gahl; Stephen Groft; Cynthia Tifft; Domenica Taruscio; Paul Lasko; Kenjiro Kosaki; Helene Wilhelm; Bela Melegh; Jonathan Carapetis; Sayanta Jana; Gervase Chaney; Allison Johns; Peter Wynn Owen; Frank Daly; Tarun Weeramanthri; Hugh Dawkins; Jack Goldblatt
Journal:  Orphanet J Rare Dis       Date:  2017-05-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.